Devyser Genomic Laboratories


Devyser is a pioneer in diagnostic kits and solutions for advanced DNA testing, aiming to make personalized healthcare accessible through fast, accurate, and easy-to-use genetic testing solutions. Founded in 2004 in Stockholm, Sweden, the company develops innovative products that streamline laboratory workflows and improve patient outcomes. With a global presence in over 50 countries, Devyser is committed to innovation, simplicity, relevance, and empathy in genetic diagnostics.

Industries

biotechnology
health-diagnostics

Nr. of Employees

medium (51-250)

Devyser Genomic Laboratories

Hägersten, Stockholms Lan, Sweden, Europe


Products

Targeted NGS assay panels for clinical diagnostics

A portfolio of targeted amplicon NGS assay panels for applications including thalassemia, cystic fibrosis (CFTR), hereditary cancer, chimerism, donor-derived cfDNA monitoring, fetal RHD screening and genomic blood typing.

Regulated NGS analysis software (diagnostic-grade pipelines)

Diagnostic-grade software for NGS data analysis that includes certified pipelines for specified panels and research-use-only pipelines for others.

Post-transplant monitoring software

Specialized software for longitudinal analysis and reporting of transplant monitoring assays, including timelines and clinical visualization for chimerism and donor-derived cfDNA.


Services

Clinical testing services (in-house accredited laboratory)

Diagnostic testing and reporting services performed in an accredited clinical laboratory environment.

On-site and remote implementation and training

Operational and technical support, including hands-on and online training for assay implementation and bioinformatics use.

Cloud-hosted and on-site bioinformatics software deployment

Deployment and hosting of regulated NGS analysis software with options for cloud hosting or secure local installation.

Expertise Areas

  • NGS-based diagnostic assay development
  • Post-transplant monitoring and chimerism analysis
  • Chimerism assay design using population-independent marker panels
  • Clinical bioinformatics and variant interpretation
  • Show More (4)

Key Technologies

  • Next-generation sequencing (targeted amplicon NGS)
  • Variant calling and annotation (SNV/indel/CNV)
  • Donor-derived cell-free DNA quantification by NGS
  • Chimerism measurement by NGS
  • Show More (5)

Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.